Ordin nr. 1301/500/2008 din 11 iulie 2008 Partea a ii-a
tratamentul local a cel puţin două episoade
Yüklə 4,39 Mb.
|
tratamentul local a cel puţin două episoade. Candidoza orală la persoanele imunocompromise sever la care tratamentul local nu a avut rezultate Micoze sistemice la care alte forme de terapie antifungică nu au avut efect. A fost raportată hepatotoxicitate la ketoconazol. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AB02 KETOCONAZOLUM COMPR. 200 mg KEFUNGIN 200 mg ANTIBIOTICE SA KETOCONAZOL 200 mg 200 mg MAGISTRA C & C KETOSTIN 200 mg 200 mg AC HELCOR SRL NIZORAL 200 mg JANSSEN PHARMACEUTICA NV NIZORAL 200 mg 200 mg TERAPIA SA
KEFUNGIN 200 mg ANTIBIOTICE SA KETOCONAZOL 200 mg 200 mg MAGISTRA C & C KETOSTIN 200 mg 200 mg AC HELCOR SRL NIZORAL 200 mg JANSSEN PHARMACEUTICA NV NIZORAL 200 mg 200 mg TERAPIA SA ________________________________________________________________________________
| 971 |J02AC01| FLUCONAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC01 FLUCONAZOLUM CAPS. 100 mg DIFLAZON 100 mg 100 mg KRKA D.D. FLUCONAZOLE TEVA 100 mg 100 mg TEVA PHARMACEUTICALS SRL FLUCORIC 100 mg 100 mg TERAPIA S.A. FLUCOVIM 100 100 mg VIM SPECTRUM SRL FUNGOLON 100 mg 100 mg BALKANPHARMA RAZGRAD AD
DIFLAZON 150 mg 150 mg KRKA D.D. DIFLUCAN 150 mg 150 mg PFIZER EUROPE MA EEIG FLUCONAZOL 150 mg 150 mg OZONE LABORATORIES LTD. FLUCONAZOL MEDICO UNO 150 mg 150 mg MEDICO UNO PHARMACEUTICAL SRL
FLUCONAZOL MEDOCHEMIE 150 mg 150 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 150 150 mg SANDOZ SRL FLUCONAZOL TERAPIA 150 mg 150 mg TERAPIA SA FLUCONAZOLE TEVA 150 mg 150 mg TEVA PHARMACEUTICALS SRL FLUCORIC 150 mg 150 mg TERAPIA S.A. FLUCOVIM 150 150 mg VIM SPECTRUM SRL MYCOMAX 150 150 mg ZENTIVA AS MYCOSYSTA(R) 150 mg 150 mg GEDEON RICHTER PLC. J02AC01 FLUCONAZOLUM CAPS. 200 mg DIFLAZON 200 mg 200 mg KRKA D.D. FLUCONAZOLE TEVA 200 mg 200 mg TEVA PHARMACEUTICALS SRL
DIFLAZON(R) 2 mg/ml KRKA D.D. DIFLUCAN(R) 2 mg/ml PFIZER EUROPE MA EEIG MYCOMAX(R) INF 2 mg/ml ZENTIVA AS J02AC01 FLUCONAZOLUM CAPS. 50 mg DIFLAZON 50 mg 50 mg KRKA D.D. DIFLUCAN 50 mg 50 mg PFIZER EUROPE MA EEIG FLUCONAZOL 50 mg 50 mg ARENA GROUP SA FLUCONAZOL MEDOCHEMIE 50 mg 50 mg MEDOCHEMIE ROMANIA SRL FLUCONAZOL SANDOZ(R) 50 50 mg SANDOZ SRL FLUCONAZOL TERAPIA 50 mg 50 mg TERAPIA S.A. FLUCONAZOLE TEVA 50 mg 50 mg TEVA PHARMACEUTICALS SRL FLUCORIC 50 mg 50 mg TERAPIA S.A. FLUCOVIM 50 50 mg VIM SPECTRUM SRL FUNGOLON 50 mg 50 mg BALKANPHARMA RAZGRAD AD
DIFLUCAN(R) 50 mg/5 ml 50 mg/5 ml PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 972 |J02AC02| ITRACONAZOLUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC02 ITRACONAZOLUM CAPS. 100 mg ITRACONAZOL 100 mg 100 mg TERAPIA S.A. OMICRAL 100 mg 100 mg MEDICO UNO PHARMACEUTICAL S.R.L ORUNGAL 100 mg JANSSEN PHARMACEUTICA NV SPORILIN 100 mg 100 mg GEDEON RICHTER ROMANIA S.A.
Prescriere limitată: Sporotricoza sistemică Prescriere limitată: Profilaxia secundară a candidozei orofaringiene la pacienţi cu imunosupresie Prescriere limitată: Tratamentul candidozei orofaringiene la pacienţi cu imunosupresie ________________________________________________________________________________ ______________________________________________________________________________ | 973 |J02AC03| VORICONAZOLUM** | Protocol: J012B | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC03 VORICONAZOLUM COMPR. FILM. 200 mg VFEND 200 mg 200 mg PFIZER LTD.
VFEND 200 mg 200 mg PFIZER LTD. J02AC03 VORICONAZOLUM PULB. PT. SUSP. ORALA 40 mg/ml VFEND 40 mg/ml 40 mg/ml PFIZER LTD. J02AC03 VORICONAZOLUM COMPR. FILM. 50 mg VFEND 50 mg 50 mg PFIZER LTD. ________________________________________________________________________________
| 974 |J02AX04| CASPOFUNGINUM** | Protocol: J010D | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. 50 mg SOL. PERF. CANCIDAS 50 mg 50 mg MERCK SHARP & DOHME LTD J02AX04 CASPOFUNGINUM PULB. PT. CONC. PT. 70 mg SOL. PERF. CANCIDAS 70 mg 70 mg MERCK SHARP & DOHME LTD ________________________________________________________________________________ ______________________________________________________________________________ | 976 |J05AB01| ACICLOVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB01 ACICLOVIRUM CAPS. 200 mg ACICLOVIR 200 mg 200 mg SLAVIA PHARM SRL EUVIROX 200 mg 200 mg EUROPHARM SA J05AB01 ACICLOVIRUM COMPR. 200 mg ACICLOVIR 200 mg 200 mg TERAPIA SA CLOVIRAL 200 mg 200 mg ANTIBIOTICE SA ZOVIRAX 200 mg GLAXO WELLCOME FOUNDATION LTD.
ACICLOVIR 200 mg 200 mg OZONE LABORATORIES LTD. LOVIR 200 mg 200 mg RANBAXY UK LIMITED
INJ./PERF. VIROLEX 250 mg KRKA D.D. NOVO MESTO
ACICLOVIR 400 mg 400 mg ARENA GROUP S.A. J05AB01 ACICLOVIRUM COMPR. 400 mg ACICLOVIR 400 mg 400 mg EGIS PHARMACEUTICALS P.L.C.
ACIKLOVIR 400 mg A & G MED TRADING S.R.L. ________________________________________________________________________________
| 977 |J05AB14| VALGANCICLOVIRUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL ________________________________________________________________________________ ______________________________________________________________________________ | 978 |J05AB11| VALACYCLOVIRUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB11 VALACYCLOVIRUM COMPR. FILM. 500 mg VALTREX 500 mg 500 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 980 |L01AA01| CYCLOPHOSPHAMIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 1 g INJ./PERF. ENDOXAN(R) 1 g 1 g BAXTER ONCOLOGY GMBH L01AA01 CYCLOPHOSPHAMIDUM PULB. PT. SOL. 200 mg PERF./INJ. I.V. ENDOXAN 200 mg 200 mg ACTAVIS S.R.L.
INJ./PERF. ENDOXAN(R) 500 mg 500 mg BAXTER ONCOLOGY GMBH
ENDOXAN(R) 50 mg 50 mg BAXTER ONCOLOGY GMBH ________________________________________________________________________________
| 981 |L03AA02| FILGRASTIMUM (G-CSF) | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L03AA02 FILGRASTIMUM (G-CSF) SOL. INJ. 30 MU/0.5 ml NEUPOGEN(R) 30 MU/0.5 ml AMGEN EUROPE B.V.
NEUPOGEN(R) 48 MU/0.5 ml AMGEN EUROPE B.V. ________________________________________________________________________________
| 982 |L04AA01| CICLOSPORINUM | | |_______|_______|____________________________________________|_________________|
Monitorizarea atentă a pacienţilor este obligatorie. Se aplică tuturor denumirilor comerciale, formelor farmaceutice şi concentraţiilor corespunzătoare DCI-ului. ________________________________________________________________________________ DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA01 CICLOSPORINUM CAPS. MOI 100 mg EQUORAL(R) 100 mg 100 mg IVAX - PHARMACEUTICALS S.R.O.
EQUORAL(R) 100 mg/ml IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 100 mg/ml NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 25 mg CICLORAL(R) HEXAL(R) 25 mg 25 mg HEXAL AG EQUORAL(R) 25 mg 25 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 25 mg NOVARTIS PHARMA GMBH L04AA01 CICLOSPORINUM CAPS. MOI 50 mg CICLORAL(R) HEXAL 50 mg 50 mg HEXAL AG EQUORAL(R) 50 mg 50 mg IVAX - PHARMACEUTICALS S.R.O.
SANDIMMUN NEORAL(R) 50 mg NOVARTIS PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 984 |L04AA05| TACROLIMUSUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA05 TACROLIMUSUM CAPS. ELIB. PREL 0,5 mg ADVAGRAF 0,5 mg 0,5 mg ASTELLAS PHARMA GMBH
PROGRAF(R) 0,5 mg 0.5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. 1 mg PROGRAF(R) 1 mg 1 mg ASTELLAS IRELAND CO. LTD. L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 1 mg ADVAGRAF 1 mg 1 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. 5 mg PROGRAF(R) 5 mg 5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CAPS. ELIB. PREL. 5 mg ADVAGRAF 5 mg 5 mg ASTELLAS PHARMA GMBH L04AA05 TACROLIMUSUM CONC. PT. SOL. PERF. 5 mg/ml PROGRAF(R) 5 mg/ml 5 mg/ml ASTELLAS PHARMA GMBH ________________________________________________________________________________
| 985 |L04AA06| MYCOPHENOLATUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA06 MYCOPHENOLATUM COMPR. FILM. GASTROREZ. 180 mg MYFORTIC 180 mg 180 mg NOVARTIS PHARMA GMBH
CELLCEPT 1 mg/5 ml 1 g/5 ml ROCHE REGISTRATION LTD. L04AA06 MYCOPHENOLATUM CAPS. 250 mg CELLCEPT 250 mg 250 mg ROCHE REGISTRATION LTD. MYFENAX 250 mg 250 mg TEVA PHARMA BV
MYFORTIC 360 mg 360 mg NOVARTIS PHARMA GMBH L04AA06 MYCOPHENOLATUM CAPS. 500 mg MYFENAX 500 mg 500 mg TEVA PHARMA BV L04AA06 MYCOPHENOLATUM COMPR. FILM. 500 mg CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD. L04AA06 MYCOPHENOLATUM PULB. PT. CONC. PT. 500 mg SOL. PERF. CELLCEPT 500 mg 500 mg ROCHE REGISTRATION LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 986 |L04AA08| DACLIZUMABUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA08 DACLIZUMABUM CONC. PT. SOL. PERF. 5 mg/ml ZENAPAX 5 mg/ml 5 mg/ml ROCHE REGISTRATION LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 987 |L04AA09| BASILIXIMABUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA09 BASILIXIMABUM LIOF. + SOLV. PT. SOL. 20 mg INJ./PERF. SIMULECT 20 mg 20 mg NOVARTIS EUROPHARM LTD. ________________________________________________________________________________
| 988 |L04AA10| SIROLIMUS** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AA10 SIROLIMUS COMPR. FILM. 1 mg RAPAMUNE 1 mg 1 mg WYETH EUROPA LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 989 |L04AX01| AZATHIOPRINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ L04AX01 AZATHIOPRINUM COMPR. FILM. 50 mg IMURAN(R) 50 mg THE WELLCOME FOUNDATION LTD.
________________________________________________________________________________ ______________________________________________________________________________ | 990 |M05BA04| ACIDUM ALENDRONICUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ M05BA04 ACIDUM ALENDRONICUM COMPR. 10 mg FOSAMAX 10 mg 10 mg MERCK SHARP & DOHME S.R.L.
TEVA NAT 70 mg TEVA PHARMACEUTICALS SRL M05BA04 ACIDUM ALENDRONICUM COMPR. 70 mg FOSAMAX 70 mg 70 mg MERCK SHARP & DOHME S.R.L. ________________________________________________________________________________
| 991 |N02AB02| PETHIDINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ N02AB02 PETHIDINUM SOL. INJ. 50 mg/ml MIALGIN(R) 100 mg/2 ml 50 mg/ml ZENTIVA SA ________________________________________________________________________________ ______________________________________________________________________________ | 993 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. CLIVARIN (R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG B01AB08 REVIPARINUM SOL. INJ. CLIVARIN (R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________ ______________________________________________________________________________ | 994 |B05AA06| POLYGELINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B05AA06 POLYGELINUM SOL. PERF. 3.5% HAEMACCEL 3.5% THERASELECT GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 995 |J01XX08| LINEZOLIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEI ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG J01XX08 LINEZOLIDUM SOL. PERF. ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEI ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG
ZYVOXID(R) 600 mg PFIZER EUROPE MA EEI ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________ ______________________________________________________________________________ | 996 |J02AC03| VORICONAZOLUM** | Protocol: J012B | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J02AC03 VORICONAZOLUM COMPR. FILM. VFEND(R) 200 mg PFIZER LIMITED VFEND 200 mg 200 mg PFIZER LTD. J02AC03 VORICONAZOLUM PULB. PT. SOL. PERF. VFEND(R) 200 mg PFIZER LIMITED VFEND 200 mg 200 mg PFIZER LTD.
VFEND(R) 40 mg/ml 40 mg/ml PFIZER LIMITED VFEND 40 mg/ml 40 mg/ml PFIZER LTD.
VFEND(R) 50 mg PFIZER LIMITED VFEND 50 mg 50 mg PFIZER LTD. ________________________________________________________________________________ ______________________________________________________________________________ | 998 |J05AB14| VALGANCICLOVIRUM** | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J05AB14 VALGANCICLOVIRUM COMPR. FILM. 450 mg VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL
VALCYTE(R) 450 mg 450 mg ROCHE ROMANIA SRL ________________________________________________________________________________
| 999 |B01AB05| ENOXAPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml
anti-Xa/0,4ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml B01AB05 ENOXAPARINUM SOL. INJ. 8000 ui anti-Xa/0.8 ml CLEXANE 8000 ui 8000 ui anti-Xa/0.8 ml LAB. AVENTIS anti-Xa/0.8 ml B01AB05 ENOXAPARINUM SOL. INJ. 2000 ui anti-Xa/0.2 ml CLEXANE 2000 ui 2000 ui anti-Xa/0.2 ml LAB. AVENTIS anti-Xa/0.2 ml B01AB05 ENOXAPARINUM SOL. INJ. 4000 ui anti-Xa/0,4 ml CLEXANE 4000 ui 4000 ui anti-Xa/0,4 ml LAB. AVENTIS anti-Xa/0.4 ml B01AB05 ENOXAPARINUM SOL. INJ. 6000 ui anti-Xa/0.6 ml CLEXANE 6000 ui 6000 ui anti-Xa/0.6 ml LAB. AVENTIS anti-Xa/0.6 ml ________________________________________________________________________________
| 1000 |B01AB08| REVIPARINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ B01AB08 REVIPARINUM SOL. INJ. 1432 ui/0.25 ml CLIVARIN(R) 1432 UI/0.25 ml 1432 ui/0.25 ml ABBOTT GMBH & CO. KG
CLIVARIN(R) 3436 UI/0,6 ml 3436 ui/0.6 ml ABBOTT GMBH & CO. KG ________________________________________________________________________________
| 1002 |C01CA24| EPINEPHRINUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ C01CA24 EPINEPHRINUM SOL. INJ. 1 mg/ml ADRENALINA 1 mg 1 mg/ml TERAPIA SA ________________________________________________________________________________ ______________________________________________________________________________ | 1003 |J01CR05| PIPERACILLINUM + TAZOBACTAMUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01CR05 PIPERACILLINUM + LIOF. PT. SOL. INJ. TAZOBACTAMUM TAZOCIN 2,25 WYETH LEDERLE PHARMA GMBH TAZOCIN 4,5 WYETH LEDERLE PHARMA GMBH ________________________________________________________________________________ ______________________________________________________________________________ | 1004 |J01XX08| LINEZOLIDUM | | |_______|_______|____________________________________________|_________________|
DCI/DENUMIRE COMERCIALĂ FORMA FARM. __________________________________________________ CONCENTRAŢIE FIRMA ________________________________________________________________________________ J01XX08 LINEZOLIDUM GRAN. PT. SUSP. ORALA 100 mg/5 ml ZYVOXID(R) 100 mg/5 ml PFIZER EUROPE MA EEIG
ZYVOXID(R) 2 mg/ml PFIZER EUROPE MA EEIG J01XX08 LINEZOLIDUM COMPR. FILM. 600 mg ZYVOXID(R) 600 mg PFIZER EUROPE MA EEIG ________________________________________________________________________________
| 1005 |J02AC01| FLUCONAZOLUM | | |_______|_______|____________________________________________|_________________|
Yüklə 4,39 Mb. Dostları ilə paylaş:
|